相关实验视频

Updated: Mar 14, 2026

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents

Published on: July 8, 2015

孟坦丁减轻了大鼠在社会和识别记忆中甲胺诱导的损伤

Mehdi Khodamoradi¹, Yasaman Allameh², Melika Sarani³

¹Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

BMC neuroscience

|June 5, 2025

概括

孟坦丁 (MEM) 治疗逆转了由甲基胺 (METH) 神经毒性引起的记忆和社会行为缺陷. 这项研究显示了MEMEM.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
毒理学毒理学毒理学

背景情况:

甲基胺 (METH) 是一种神经毒性物质,与认知障碍有关.
孟曼丁 (MEM) 是一种NMDA受体对手,显示出改善认知功能的潜力.
众所周知,METH暴露会导致社会和认知障碍.

研究的目的:

研究MEM对社会记忆,社会行为和慢性METH暴露引起的新型物体识别障碍的影响.
评估MEM对METH诱导的神经毒性的神经保护潜力.

主要方法:

成年雄性Wistar大鼠被给予METH以诱导神经毒性.
在暴露于METH后,大鼠接受了MEM的治疗.
评估了新的对象识别记忆和社会行为.

主要成果:

暴露于METH显著损害了新的对象识别记忆 (获取,整合,检索).
MEM治疗改善了METH诱导的记忆缺陷,但没有重新巩固.
在社会互动和行为方面,MEM改善了METH触发的缺陷.

结论:

给予MEM有效地改善了慢性METH暴露引起的记忆障碍.
MEM对新的对象记忆,社会记忆和社会行为表现出神经保护作用.
研究结果表明,MEM是METH诱导的神经认知缺陷的潜在治疗剂.

关键词:

记忆剂记忆剂记忆剂甲基胺是一种甲基胺.新型的对象识别记忆器社会互动社交互动社会记忆社会记忆

更多相关视频

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Published on: October 29, 2019

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Published on: July 29, 2018

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.